Show simple item record

Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection

dc.contributor.authorMcCarthy, Conor J.en_US
dc.contributor.authorCrofford, Leslie J.en_US
dc.contributor.authorGreenson, Joel K.en_US
dc.contributor.authorScheiman, James M.en_US
dc.date.accessioned2010-06-01T21:27:01Z
dc.date.available2010-06-01T21:27:01Z
dc.date.issued1999-05en_US
dc.identifier.citationMcCarthy, Conor J . ; Crofford, Leslie J . ; Greenson, Joel; Scheiman, James M . (1999). "Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection." The American Journal of Gastroenterology 94(5): 1218-1223. <http://hdl.handle.net/2027.42/74509>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74509
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10235197&dopt=citationen_US
dc.description.abstractHelicobacter pylori ( H. pylori ) causes chronic gastritis. The inducible prostaglandin synthetase cyclooxygenase 2 (COX-2) plays an important role in inflammatory conditions. We hypothesized that H. pylori -associated chronic gastritis would express COX-2 protein. Our aim was to evaluate the effect of eradication of H. pylori infection on COX-2 expression in the antral mucosa of patients before and after antibiotic therapy. Methods : Tissues were obtained from patients with nonulcer dyspepia undergoing H. pylori eradication. Ten patients with proven H. pylori infection and subsequent successful eradication were studied. Three biopsies of antral mucosa were evaluated before and after H. pylori eradication. The amount of acute and chronic inflammation was quantitated. Immunohistochemical staining for COX-2 was expressed as a percentage of the total number of cells and correlated with the degree of chronic inflammation. Results : Specific immunostaining for COX-2 was observed in antral mucosa of patients infected with H. pylori . Patchy cytoplasmic staining was seen in surface epithelial cells and strong cytoplasmic staining for COX-2 was seen in parietal cells. Spotty cytoplasmic staining for COX-2 was also seen in lamina propria plasma cells, as well as there being macrophages present in the germinal centers of lymphoid aggregates. COX-2 expression could be detected both before and after eradication of H. pylori . The mean percentage of cells staining for COX-2 was significantly higher in H. pylori -infected mucosa, compared with mucosa after successful H. pylori eradication ( 33.4%± 5.4 vs 18.9%± 3.3 , p = 0.038 ). COX-2 immunostaining correlated best with the chronic inflammation score ( r 2 = 0.78 , p < 0.001 ). There was a strong correlation for those subjects who were H. pylori infected, as well as for those who had successful H. pylori eradication. Conclusions : H. pylori associated acute and chronic antral inflammation was associated with immunohistochemical detection of COX-2 protein in epithelial cells, in addition to associated mononuclear cells and parietal cells. Expression was reduced, but not eliminated, in the epithelium after successful eradication of H. pylori . Despite the reduction in COX-2 expression after H. pylori eradication, expression of COX-2 in epithelial cells remained and strongly correlated with the extent of the chronic inflammatory cell infiltrate. The clinical implications of H. pylori -associated induction of COX-2 expression for patients on selective COX-2 inhibitors, in addition to the role of COX-2 in gastric carcinogenesis, deserve further study.en_US
dc.format.extent412723 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/octet-stream
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights1999 by Am. Coll. of Gastroenterologyen_US
dc.titleCyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infectionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Rheumatology University of Michigan Medical Center, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Gastroenterology University of Michigan Medical Center, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid10235197en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74509/1/j.1572-0241.1999.01070.x.pdf
dc.identifier.doi10.1111/j.1572-0241.1999.01070.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceScheiman J.M.. NSAIDs, cytoprotection, and gastrointestinal injury. Gastroenterol Clin N Am 1996; 25: 279 – 298.en_US
dc.identifier.citedreferenceCrofford L.J.. COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 1997; 24 ( suppl 49 ): 15 – 19.en_US
dc.identifier.citedreferenceKargman S., Charleson S., Cartwright M., et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 1996; 111: 445 – 454.en_US
dc.identifier.citedreferenceMizuno H., Sakamoto C., Matsuda K., et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997; 112: 387 – 397.en_US
dc.identifier.citedreference5. Infection with Helicobacter pylori. In: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistosomes, Liver Flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Lyon, France: International Agency for Research on Cancer, 1994: 177 – 240.en_US
dc.identifier.citedreferenceRistimaki A., Honkanen N., Jankala H., et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997; 57: 1276 – 1280.en_US
dc.identifier.citedreferenceElta G.H., Scheiman J.M., Barnett J.L., et al. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Am J Gastroenterol 1995; 90: 1089 – 1093.en_US
dc.identifier.citedreferenceTo K.F., Chan F.K.L., Leung W.K., et al. Expression of cyclooxygenase 1 (COX-1) and 2) (COX-2) in H. pylori associated gastritis. Gastroenterology 1998; 114: A310.en_US
dc.identifier.citedreferenceJackson L.M., Wu K., Mahida Y.R., et al. COX-1 expression in human gastric mucosa infected with Helicobacter pylori: Constitutive or induced?. Gastroenterol 1998; 114: A160.en_US
dc.identifier.citedreferenceWu K.C., Jackson L., Mahida Y.R., et al. Cyclooxygenase (COX-1)-and 2 in human gastric mucosa: Constitutive expression by parietal cells and induction of COX-2 in lamina propria cells proximal to ulcers. Gastroenterol 1998; 114: A334.en_US
dc.identifier.citedreferenceSheng H., Shao J., Kirkland S.C., et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 99: 2254 – 2259.en_US
dc.identifier.citedreferenceThun M.J.. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev 1994; 13: 279 – 283.en_US
dc.identifier.citedreferenceChan F.K.L., Sung J.J.K., Chung S.C.C., et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975 – 979.en_US
dc.identifier.citedreferenceHawkey C.J., Karrasch J.A., Szczepanski L., et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727 – 734.en_US
dc.identifier.citedreferenceRomano M., Ricci V., Memoli A., et al. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 1998; 273: 28560 – 28563.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.